-
公开(公告)号：US11479552B2
公开(公告)日：2022-10-25
申请号：US17376452
申请日：2021-07-15
Applicant: Eisai R&D Management Co., Ltd.
Inventor： Yu Yoshida , Yoichi Kita , Makoto Kotake , Keiichi Sorimachi , Toshiyuki Ohfusa , Takafumi Motoki , Taro Asaba
IPC: C07D401/14 , C07D471/08
Abstract: Provided are compounds represented by the following formulas (I), (II), (III) and (IV) having orexin type 2 receptor-activating activity, or their pharmaceutically acceptable salts.
-
公开(公告)号：US11358972B2
公开(公告)日：2022-06-14
申请号：US16807335
申请日：2020-03-03
Applicant: Eisai R&D Management Co., Ltd.
Inventor： Yoshiaki Ohashi , Yoshihiko Norimine , Tamaki Hoshikawa , Yu Yoshida , Yoshihisa Kobayashi , Nobuhiro Sato , Koji Hagiwara , Nobuaki Sato , Shinsuke Hirota , Takaaki Harada , Hikaru Yoshimura
IPC: C07D495/22 , A61K31/551 , A61P25/00 , C07D491/22 , C07D491/147
Abstract: The present invention provides compounds represented by formulas (I) to (XVII) or pharmaceutically acceptable salts thereof:
-
公开(公告)号：US20200283452A1
公开(公告)日：2020-09-10
申请号：US16807335
申请日：2020-03-03
Applicant: Eisai R&D Management Co., Ltd.
Inventor： Yoshiaki Ohashi , Yoshihiko Norimine , Tamaki Hoshikawa , Yu Yoshida , Yoshihisa Kobayashi , Nobuhiro Sato , Koji Hagiwara , Nobuaki Sato , Shinsuke Hirota , Takaaki Harada , Hikaru Yoshimura
IPC: C07D495/22 , C07D491/147 , C07D491/22
Abstract: The present invention provides compounds represented by formulas (I) to (XVII) or pharmaceutically acceptable salts thereof:
-
公开(公告)号：US20190071452A1
公开(公告)日：2019-03-07
申请号：US16122116
申请日：2018-09-05
Applicant: Eisai R&D Management Co., Ltd.
Inventor： Yoshiaki Ohashi , Yoshihiko Norimine , Tamaki Hoshikawa , Yu Yoshida , Yoshihisa Kobayashi , Nobuhiro Sato , Koji Hagiwara
IPC: C07D495/22 , A61P25/28 , A61P25/16
Abstract: The present invention provides compounds represented by formulas (I) to (VI) or pharmaceutically acceptable salts thereof.
-
Patent Agency Ranking
公开(公告)号：US11267821B2
公开(公告)日：2022-03-08
申请号：US16807335
申请日：2020-03-03
Applicant: Eisai R&D Management Co., Ltd.
Inventor： Yoshiaki Ohashi , Yoshihiko Norimine , Tamaki Hoshikawa , Yu Yoshida , Yoshihisa Kobayashi , Nobuhiro Sato , Koji Hagiwara , Nobuaki Sato , Shinsuke Hirota , Takaaki Harada , Hikaru Yoshimura
IPC: C07D495/22 , A61K31/551 , A61P25/00 , C07D491/22 , C07D491/147
Abstract: The present invention provides compounds represented by formulas (I) to (XVII) or pharmaceutically acceptable salts thereof:
-
公开(公告)号：US20170137436A1
公开(公告)日：2017-05-18
申请号：US15346912
申请日：2016-11-09
Applicant: Eisai R&D Management Co., Ltd.
Inventor： Toshiki Kurokawa , Yu Yoshida , Kogyoku Shin , Yoshihisa Kobayashi , Hironori Fukumoto , Kunitoshi Takeda , Yoshiaki Ohashi , Makoto Kotake , Tomoyuki Shibuguchi , Toru Watanabe , Yoichi Kita , Shinsuke Hirota , Takashi Fukuyama , Yasuaki Kamada
IPC: C07D491/147 , C07D491/052
CPC classification number: C07D491/147 , C07D491/052
Abstract: Compounds represented by formulae (I) to (XXII) or pharmaceutically acceptable salts thereof:
-
7.发明授权Methods and compounds useful in the synthesis of orexin-2 receptor antagonists 有权用于合成食欲肽-2受体拮抗剂的方法和化合物公开(公告)号：US09416109B2
公开(公告)日：2016-08-16
申请号：US14379063
申请日：2013-02-14
Applicant: Eisai R&D Management Co., Ltd.
Inventor： George Anthony Moniz , Annie Zhu Wilcoxen , Farid Benayoud , Jaemoon Lee , Huiming Zhang , Taro Terauchi , Ayumi Takemura , Yu Yoshida , Toshiaki Tanaka , Keiichi Sorimachi , Yoshimitsu Naoe , Yuji Kazuta
IPC: C07D239/34 , C07C69/16 , C07C309/66 , C12P7/22 , C07C309/73 , C07D401/12 , C07C303/28 , C07C29/147
CPC classification number: C07C309/73 , C07B2200/07 , C07C29/147 , C07C69/16 , C07C303/28 , C07C303/44 , C07C309/66 , C07C2601/02 , C07D239/34 , C07D401/12 , C12P7/22 , C07C33/50
Abstract: The present disclosure provides compounds and methods that are useful for the preparation of compounds useful as orexin-2 receptor antagonists.
Abstract translation: 本公开提供了可用于制备可用作食欲素-2受体拮抗剂的化合物的化合物和方法。
-
公开(公告)号：US10239889B1
公开(公告)日：2019-03-26
申请号：US16122116
申请日：2018-09-05
Applicant: Eisai R&D Management Co., Ltd.
Inventor： Yoshiaki Ohashi , Yoshihiko Norimine , Tamaki Hoshikawa , Yu Yoshida , Yoshihisa Kobayashi , Nobuhiro Sato , Koji Hagiwara
IPC: A61K31/551 , A61P25/00 , C07D495/22 , A61P25/16 , A61P25/28
Abstract: The present invention provides compounds represented by formulas (1) to (VI) or pharmaceutically acceptable salts thereof:
-
公开(公告)号：US09738656B2
公开(公告)日：2017-08-22
申请号：US15346912
申请日：2016-11-09
Applicant: Eisai R&D Management Co., Ltd.
Inventor： Toshiki Kurokawa , Yu Yoshida , Kogyoku Shin , Yoshihisa Kobayashi , Hironori Fukumoto , Kunitoshi Takeda , Yoshiaki Ohashi , Makoto Kotake , Tomoyuki Shibuguchi , Toru Watanabe , Yoichi Kita , Shinsuke Hirota , Takashi Fukuyama , Yasuaki Kamada
IPC: C07D491/147 , C07D491/052
CPC classification number: C07D491/147 , C07D491/052
Abstract: Compounds represented by formulae (I) to (XXII) or pharmaceutically acceptable salts thereof:
-
-
-
-
-
-
-
-
Search Results
9
records
(took 0.02 seconds)
